Sio Gene Therapies SIOX Stock
Sio Gene Therapies Price Chart
Sio Gene Therapies SIOX Financial and Trading Overview
| Sio Gene Therapies stock price | USD |
| Previous Close | 0.4 USD |
| Open | 0.4 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 1000 |
| Day's Range | 0.4 - 0.41 USD |
| 52 Week Range | 0.26 - 0.47 USD |
| Volume | 58.37K USD |
| Avg. Volume | 262.67K USD |
| Market Cap | 29.66M USD |
| Beta (5Y Monthly) | 1.477832 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SIOX Valuation Measures
| Enterprise Value | -16244720 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.28642857 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.657377 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.598 |
Trading Information
Sio Gene Therapies Stock Price History
| Beta (5Y Monthly) | 1.477832 |
| 52-Week Change | 9.26% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.47 USD |
| 52 Week Low | 0.26 USD |
| 50-Day Moving Average | 0.41 USD |
| 200-Day Moving Average | 0.38 USD |
SIOX Share Statistics
| Avg. Volume (3 month) | 262.67K USD |
| Avg. Daily Volume (10-Days) | 37.32K USD |
| Shares Outstanding | 73.98M |
| Float | 55.28M |
| Short Ratio | 0.11 |
| % Held by Insiders | 25.30% |
| % Held by Institutions | 25.52% |
| Shares Short | 71.39K |
| Short % of Float | 0.13% |
| Short % of Shares Outstanding | 0.10% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.33% |
| Return on Equity (ttm) | -47.50% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -27152000 USD |
| Net Income Avi to Common (ttm) | -28829000 USD |
| Diluted EPS (ttm) | -0.39 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 46.13M USD |
| Total Cash Per Share (mrq) | 0.62 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 21.967 |
| Book Value Per Share (mrq) | 0.61 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -36508000 USD |
| Levered Free Cash Flow (ttm) | -24671124 USD |
Profile of Sio Gene Therapies
| Country | United States |
| State | NY |
| City | New York |
| Address | 130 West 42nd Street |
| ZIP | 10036 |
| Phone | 877 746 4891 |
| Website | https://www.siogtx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.
Q&A For Sio Gene Therapies Stock
What is a current SIOX stock price?
Sio Gene Therapies SIOX stock price today per share is USD.
How to purchase Sio Gene Therapies stock?
You can buy SIOX shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sio Gene Therapies?
The stock symbol or ticker of Sio Gene Therapies is SIOX.
Which industry does the Sio Gene Therapies company belong to?
The Sio Gene Therapies industry is Biotechnology.
How many shares does Sio Gene Therapies have in circulation?
The max supply of Sio Gene Therapies shares is 0.
What is Sio Gene Therapies Price to Earnings Ratio (PE Ratio)?
Sio Gene Therapies PE Ratio is 0.00000000 now.
What was Sio Gene Therapies earnings per share over the trailing 12 months (TTM)?
Sio Gene Therapies EPS is 0 USD over the trailing 12 months.
Which sector does the Sio Gene Therapies company belong to?
The Sio Gene Therapies sector is Healthcare.
Sio Gene Therapies SIOX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
- {{ link.label }} {{link}}